Arabic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Role of Mitochondria in Non Severe Asthma

يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
يتم حفظ الارتباط في الحافظة
الحالةمنجز
الرعاة
University Hospital, Bordeaux

الكلمات الدالة

نبذة مختصرة

Asthma is a frequent disease characterized by bronchial hyperresponsiveness, inflammation and remodelling. Bronchial remodelling is an abnormal repair process that contributes to the development of poorly reversible airway narrowing. It can appear very early in the evolution of the disease and involves an increased mass of bronchial smooth muscle (BSM). The mechanism of such an increase has been related with an increase in smooth muscle cell proliferation. Recently, we have demonstrated that, BSM increased proliferation is induced by an enhanced mitochondrial biogenesis in severe asthma (T. Trian et al. J Exp Med 2007). The objective of this study is to investigate the role of smooth muscle cell mitochondria in non severe asthma

وصف

Bronchial remodelling mainly involves an increased mass of bronchial smooth muscle (BSM), which is related with an increase proliferation of BSM cells. Recently, using BSM cells obtained from severe asthmatics, we have demonstrated that such an increase proliferation was induced by an activation cascade involving an abnormal calcium entry, and the subsequent activation of Calmodulin-kinase IV, PGC-1alpha, NRF-1 and mt-TFA leading to an increase mitochondrial biogenesis (T. Trian et al, J Exp Med 2007). The objective of this study is to investigate the role of BSM cell mitochondria in non severe asthma.

For this purpose, 30 non severe asthmatic adult patients (>18 yr) will be prospectively recruited from the "CHU de Bordeaux" according to the Global Initiative for Asthma (GINA) guidelines. Inclusion visit will include written informed consent, asthma control questionnaire, clinical examination, lung function testing (i.e. arterial gas, exhaled NO, plethysmography), prick tests, chest X Ray and blood sample for total IgE levels. Bronchial specimens will be obtained from all subjects by fiberoptic bronchoscopy. BSM remodelling will be evaluated by morphological analysis. Patients will be divided into 2 groups according to the presence or the absence of BSM remodelling. Using BSM cell culture, the role of mitochondria will be analyzed by electronic microscopy, confocal microscopy, immunoblotting, RT-PCR and oxygraphy.

تواريخ

آخر التحقق: 01/31/2010
تم الإرسال لأول مرة: 12/14/2008
تم إرسال التسجيل المقدر: 12/14/2008
أول نشر: 12/15/2008
تم إرسال آخر تحديث: 02/14/2010
آخر تحديث تم نشره: 02/16/2010
تاريخ بدء الدراسة الفعلي: 01/31/2009
تاريخ الإنجاز الأساسي المقدر: 10/31/2009
التاريخ المتوقع لانتهاء الدراسة: 10/31/2009

حالة أو مرض

Asthma

التدخل / العلاج

Procedure: 1

مرحلة

-

مجموعات الذراع

ذراعالتدخل / العلاج
Experimental: 1
fiberoptic fibroscopy
Procedure: 1
Bronchial specimens will be obtained by fiberoptic bronchoscopy within 15 days after the enrolment

معايير الأهلية

الأعمار المؤهلة للدراسة 18 Years إلى 18 Years
الأجناس المؤهلة للدراسةAll
يقبل المتطوعين الأصحاءنعم
المعايير

Inclusion Criteria:

- Male or female aged more than 18 years

- Diagnosis of intermittent asthma, mild persistent asthma or moderate persistent according to ATS criteria

- Forced expiratory volume in one second > 60% predicted

- Written informed consent

Exclusion Criteria:

- Smoker or former smoker (tobacco or cannabis)

- Adults protected by law

- Subjects not affiliated with social security

- Subjects during exclusion relative to another protocol or for which the annual maximum allowance of 3800 euros has been reached

- Subject with any co-morbidity (except chronic rhinitis, chronic sinusitis nasal polyps or gastro-oesophageal reflux)

- Asthma exacerbation within 6 weeks before enrolment

- Infections of the upper airway within 3 months before enrolment

- Chronic viral infections (hepatitis, HIV)

- Pregnancy or breastfeeding

- Contraindications to bronchoscopy

النتيجة

مقاييس النتائج الأولية

1. BSM mitochondrial biogenesis assessed by the number of mitochondrial sections using electron microscopy, the porin content using western blot, and mitochondrial oxygen consumption evaluated by oxygraphy. [One bronchial fiberoptic fibroscopy within 15 days after the enrolment]

مقاييس النتائج الثانوية

1. BSM remodelling assessed by optic microscopy and immunohistochemistry (using anti-alpha smooth muscle actin antibody). [One bronchial fiberoptic fibroscopy within 15 days after the enrolment]

2. Transcription factors involved in mitochondrial biogenesis assessed by quantitative RT-PCR and western blot. [One bronchial fiberoptic fibroscopy within 15 days after the enrolment]

انضم إلى صفحتنا على الفيسبوك

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم

  • يعمل في 55 لغة
  • العلاجات العشبية مدعومة بالعلم
  • التعرف على الأعشاب بالصورة
  • خريطة GPS تفاعلية - ضع علامة على الأعشاب في الموقع (قريبًا)
  • اقرأ المنشورات العلمية المتعلقة ببحثك
  • البحث عن الأعشاب الطبية من آثارها
  • نظّم اهتماماتك وابقَ على اطلاع دائم بأبحاث الأخبار والتجارب السريرية وبراءات الاختراع

اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها.
* تستند جميع المعلومات إلى البحوث العلمية المنشورة

Google Play badgeApp Store badge